MONITORING ANTIMICROBIAL RESISTANCE AMONG INTENSIVE CARE UNIT GRAM-NEGATIVE ISOLATES: INSIGHTS FROM A RETROSPECTIVE STUDY

Authors

  • ROCKY SHARMA Department of Microbiology, Adesh Medical College and Hospital, Kurukshetra, Haryana, India.
  • JYOTI CHAUHAN Department of Microbiology, Adesh Medical College and Hospital, Kurukshetra, Haryana, India. https://orcid.org/0000-0002-5038-2612
  • ASHWINI MANHAS Department of Microbiology, Adesh Medical College and Hospital, Kurukshetra, Haryana, India.

DOI:

https://doi.org/10.22159/ajpcr.2025v18i9.55898

Keywords:

Gram-negative organisms, Intensive care units, Multidrug-resistant, Extensively drug-resistant, Pan-drug-resistant

Abstract

Objectives: To determine the distribution and resistance profiles of Gram-negative bacteria (GNB) in intensive care units (ICUs) at Tertiary care centre Adesh Medical College and Hospital, Shahabad, Kurukshetra, Haryana.

Methods: A record-based retrospective study was conducted from January 2023 to December 2024. In total, 540 clinical specimens and isolates, 58 (9.7%) GPC and 302/540(55.9%) from the general intensive care unit (ICU), neonatal ICU (NICU), Respiratory ICU, Neurology ICU and coronary CU (CCU) were analysed for pathogens and their Antibiotic susceptibility patterns.

Results: Among GNB isolates, 302/540(55.9%) were isolated in the year 2023 and 238(44.1%) were isolated in the year 2024. Predominantly isolated from the Medicine ICU, with 109 isolates in 2023 and 87 in 2024, followed by the Neuro ICU. The predominant clinical sample from which GNB were isolated was a respiratory sample for both years, with 132/302 (43.7%) for 2023 and 131/238 (55%) for 2024. Klebsiella spp. were the most frequently isolated organism, accounting for 47.7% in 2023 and 36.6% in 2024, with 231 isolates (42.8%) across both years. Acinetobacter spp. showed a marked increase, rising from 13.9% in 2023 to 26.9% in 2024. Klebsiella displayed a high resistance pattern to cephalosporin and a high rising trend of carbapenems from 19.4% in 2023 to 71.2% in 2024, followed by Acinetobacter spp., E.coli and Pseudomonas spp. Multidrug-resistant (MDR) bacteria decreased sharply from 36.42% in 2023 to 11.76% in 2024, with concomitant increase of Extensively drug-resistant (XDR) bacteria from 16.89% in 2023 to 55.46% in 2024.

Conclusion: In this study, Gram-negative bacteria caused the majority of infections in patients admitted to the intensive care unit, with Klebsiella pneumoniae being the predominant pathogen. a shift of resistance amongst isolates from MDR to XDR, pointing toward more severe and difficult-to-treat infections in ICU settings

Downloads

Download data is not yet available.

References

1. Klein EY, Impalli I, Poleon S, Denoel P, Cipriano M, Van Boeckel TP, et al. Global trends in antibiotic consumption during 2016- 2023 and future projections through 2030. Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2411919121. doi: 10.1073/pnas.2411919121, PMID 39556760, PMCID PMC11626136

2. Choudhuri AH, Chakravarty M, Uppal R. Epidemiology and characteristics of nosocomial infections in critically ill patients in a tertiary care Intensive Care Unit of Northern India. Saudi J Anaesth. 2017;11(4):402-7. doi: 10.4103/sja.SJA_230_17, PMID 29033719

3. Brusselaers N, Vogelaers D, Blot S. The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care. 2011;1(1):47. doi: 10.1186/2110-5820-1-47, PMID 22112929

4. CLSI. M100-ED34. In: Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. Wayne: Clinical and Laboratory Standards Institute; 2024.

5. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x, PMID 21793988

6. Chidambaram N, Rajan RG, Sasikala G, Anandi V. Antimicrobial profile of clinical isolates in intensive care unit at a tertiary care Hospital. Int J Med Res Health Sci. 2019;8(2):160-6.

7. Sader HS, Mendes RE, Streit JM, Carvalhaes CG, Castanheira M. Antimicrobial susceptibility of gram-negative bacteria from intensive care unit and non-intensive care unit patients from united states hospitals (2018-2020). Diagn Microbiol Infect Dis. 2021;102:115557. doi: 10.1016/j.diagmicrobio.2021.115557

8. Pattnaik D, Panda SS, Singh N, Sahoo S, Mohapatra I, Jena J. Multidrug resistant, extensively drug resistant and pan drug resistant gram negative bacteria at a tertiary care centre in Bhubaneswar. Int J Community Med Public Health. 2019;6(2):567-72. doi: 10.18203/2394- 6040.ijcmph20190170

9. Moolchandani K, Sastry AS, Deepashree R, Sistla S, Harish BN, Mandal J. Antimicrobial resistance surveillance among intensive care units of a tertiary care hospital in Southern India. J Clin Diagn Res. 2017;11(2):DC01-7.

10. Singh N, Pattnaik D, Neogi DK, Jena J, Mallick B. Prevalence of ESBL in Escherichia coli isolates among ICU patients in a tertiary care hospital. J Clin Diagn Res. 2016;10(9):DC19-22. doi: 10.7860/ JCDR/2016/21260.8544, PMID 27790433

11. Aboshakwa AM, Lalla U, Irusen EM, Koegelenberg CF. Acinetobacter baumannii infection in a medical intensive care unit: The impact of strict infection control. Afr J Thorac Crit Care Med. 2019 Apr 12;25(1):10- 13. doi: 10.7196/AJTCCM.2019.v25i1.239, PMID 34286240, PMCID PMC8278987

12. Huber CA, Sartor AL, McOdimba F, Shah R, Shivachi P, Sidjabat HE, et al. Outbreaks of multidrug-resistant Acinetobacter baumannii strains in a Kenyan teaching hospital. J Glob Antimicrob Resist. 2014 Sep;2(3):190-3. doi: 10.1016/j.jgar.2014.03.007, PMID 27873728

13. Reddy D, Morrow BM, Argent AC. Acinetobacter baumannii infections in a South African paediatric intensive care unit. J Trop Pediatr. 2015 Jun;61(3):182-7. doi: 10.1093/tropej/fmv017, PMID 25833097

14. Dash RK, Mohapatra I, Singh N, Pattnaik D, Panda SS, Smriti S, et al. A five-year trend analysis of antibacterial resistance patterns among non-fermenting Gram-negative bacilli: A retrospective study from the ICU settings of a tertiary Care Hospital. Cureus. 2024 Sep 28;16(9):e70375. doi: 10.7759/cureus.70375, PMID 39469379, PMCID PMC11516078

15. Basak S, Singh P, Rajurkar M. Multidrug resistant and extensively drug resistant bacteria: A study. J Pathog. 2016;2016:4065603. doi: 10.1155/2016/4065603, PMID 26942013

16. Oliveira VD, Rubio FG, Almeida MT, Nogueira MC, Pignatari AC. Trends of 9,416 multidrug-resistant Gram-negative bacteria. Rev Assoc Med Bras (1992). 2015;61(3):244-9. doi: 10.1590/1806- 9282.61.03.244, PMID 26248247

17. Adrizain R, Suryaningrat F, Alam A, Setiabudi D. Incidence of multidrug-resistant, extensively drug-resistant and pan-drug-resistant bacteria in children hospitalized at Dr. Hasan Sadikin general hospital Bandung Indonesia. IOP Conf S Earth Environ Sci. 2018;125:012077. doi: 10.1088/1755-1315/125/1/012077

Published

07-09-2025

How to Cite

ROCKY SHARMA, et al. “MONITORING ANTIMICROBIAL RESISTANCE AMONG INTENSIVE CARE UNIT GRAM-NEGATIVE ISOLATES: INSIGHTS FROM A RETROSPECTIVE STUDY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 9, Sept. 2025, pp. 187-91, doi:10.22159/ajpcr.2025v18i9.55898.

Issue

Section

Original Article(s)

Most read articles by the same author(s)